• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

PSMA PET/CT in the low- to intermediate-risk prostate cancer: when and why?

作者信息

Sofia Luca, Bauckneht Matteo

机构信息

Department of Health Sciences (DISSAL), University of Genova, Genova 16132, Italy.

Nuclear Medicine, IRCCS Ospedale Policlinico San Martino, Genova 16132, Italy.

出版信息

Asian J Androl. 2024 Nov 1;26(6):584-586. doi: 10.4103/aja20244. Epub 2024 Mar 26.

DOI:10.4103/aja20244
PMID:38534099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11614178/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae4/11614178/92e6ee33bc62/AJA-26-584-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae4/11614178/92e6ee33bc62/AJA-26-584-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eae4/11614178/92e6ee33bc62/AJA-26-584-g001.jpg

相似文献

1
PSMA PET/CT in the low- to intermediate-risk prostate cancer: when and why?低至中危前列腺癌中的PSMA PET/CT：何时以及为何使用？
Asian J Androl. 2024 Nov 1;26(6):584-586. doi: 10.4103/aja20244. Epub 2024 Mar 26.
2
Comparison of Ga-PSMA PET/CT and multiparametric MRI for the detection of low- and intermediate-risk prostate cancer.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描（Ga-PSMA PET/CT）与多参数磁共振成像（MRI）在检测低危和中危前列腺癌中的比较。
EJNMMI Res. 2022 Feb 11;12(1):10. doi: 10.1186/s13550-022-00881-3.
3
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
4
F-JK-PSMA-7 PET/CT for staging intermediate- or high-risk prostate cancer patients before radical prostatectomy: a pilot study.F-JK-PSMA-7 PET/CT用于根治性前列腺切除术前行分期的中高危前列腺癌患者：一项试点研究。
Eur J Hybrid Imaging. 2023 Jan 23;7(1):2. doi: 10.1186/s41824-022-00161-2.
5
Lymph node staging with 68Ga-PSMA PET in patients with intermediate and high-risk prostate cancer suitable for radical prostatectomy managed in a prostate cancer unit.在前列腺癌单 位管理的适合接受根治性前列腺切除术的中高危前列腺癌患者中，使用 68Ga-PSMA PET 进行淋巴结分期。
Chin Clin Oncol. 2023 Jun;12(3):22. doi: 10.21037/cco-23-10.
6
The Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate Cancer.PSMA PET/CT 对新诊断为不适合中危前列腺癌的男性的诊断价值。
J Nucl Med. 2023 Aug;64(8):1238-1243. doi: 10.2967/jnumed.122.265205. Epub 2023 Jun 29.
7
Diagnostic Accuracy of PSMA-targeted 18F-Florastamin PET/CT in Intermediate-risk Patients With Suspected Prostate Cancer.PSMA靶向18F-氟司他明PET/CT对疑似前列腺癌的中危患者的诊断准确性
Clin Nucl Med. 2025 Jun 1;50(6):e352-e359. doi: 10.1097/RLU.0000000000005798. Epub 2025 May 5.
8
How accurate is Gallium-prostate specific membrane antigen positron emission tomography / computed tomography (Ga-PSMA PET/CT) on primary lymph node staging before radical prostatectomy in intermediate and high risk prostate cancer? A study of patient- and lymph node- based analyses.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描（Ga-PSMA PET/CT）在中高危前列腺癌根治性前列腺切除术前对原发性淋巴结分期的准确性如何？一项基于患者和淋巴结的分析研究。
Urol Oncol. 2022 Jan;40(1):6.e1-6.e9. doi: 10.1016/j.urolonc.2021.07.006. Epub 2021 Aug 13.
9
Ga-prostate-specific membrane antigen positron emission tomography/computed tomography for patients with favorable intermediate-risk prostate cancer.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描用于低危中危前列腺癌患者
Can Urol Assoc J. 2022 Jul;16(7):E381-E385. doi: 10.5489/cuaj.7739.
10
Impact of Pelvic Lymph Node Dissection on Early Oncological Outcomes in Intermediate-Risk Prostate Cancer Patients With Node-Negative PSMA PET.盆腔淋巴结清扫术对PSMA PET检查淋巴结阴性的中危前列腺癌患者早期肿瘤学结局的影响
Prostate. 2025 Jun;85(8):777-783. doi: 10.1002/pros.24884. Epub 2025 Feb 27.

引用本文的文献

1
The continued pursuit of new strategies and new technologies.对新策略和新技术的持续追求。
Asian J Androl. 2024 Nov 1;26(6):547-548. doi: 10.4103/aja202491. Epub 2024 Oct 11.

本文引用的文献

1
The prognostic role of next-generation imaging-driven upstaging in newly diagnosed prostate cancer patients.新一代影像学驱动的升级对初诊前列腺癌患者的预后作用。
Eur J Nucl Med Mol Imaging. 2024 Feb;51(3):864-870. doi: 10.1007/s00259-023-06490-z. Epub 2023 Nov 8.
2
Diagnostic Performance and Safety of Positron Emission Tomography with F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE).F-rhPSMA-7.3 正电子发射断层扫描在初诊不利中高危前列腺癌患者中的诊断性能和安全性：一项 3 期前瞻性多中心研究（LIGHTHOUSE）的结果。
Eur Urol. 2023 Oct;84(4):361-370. doi: 10.1016/j.eururo.2023.06.018. Epub 2023 Jul 5.
3
Using PSMA imaging for prognostication in localized and advanced prostate cancer.利用前列腺特异性膜抗原（PSMA）成像对局限性和晚期前列腺癌进行预后评估。
Nat Rev Urol. 2023 Jan;20(1):23-47. doi: 10.1038/s41585-022-00670-6. Epub 2022 Dec 6.
4
Could 68Ga-PSMA PET/CT Evaluation Reduce the Number of Scheduled Prostate Biopsies in Men Enrolled in Active Surveillance Protocols?68Ga-PSMA PET/CT评估能否减少纳入主动监测方案的男性患者计划进行的前列腺活检数量？
J Clin Med. 2022 Jun 16;11(12):3473. doi: 10.3390/jcm11123473.
5
Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy.原发肿瘤 PSMA 强度是前列腺根治性切除术后生化无复发生存的独立预后生物标志物。
Eur J Nucl Med Mol Imaging. 2022 Jul;49(9):3289-3294. doi: 10.1007/s00259-022-05756-2. Epub 2022 Mar 17.
6
Ga-prostate-specific membrane antigen positron emission tomography/computed tomography for patients with favorable intermediate-risk prostate cancer.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描用于低危中危前列腺癌患者
Can Urol Assoc J. 2022 Jul;16(7):E381-E385. doi: 10.5489/cuaj.7739.
7
F-DCFPyL PET/CT in Newly Diagnosed Prostate Cancer: Diagnostic Value of Intraprostatic PSMA Uptake in Risk Classification of Prostate Cancer.F-DCFPyL PET/CT在新诊断前列腺癌中的应用：前列腺内前列腺特异性膜抗原摄取在前列腺癌风险分类中的诊断价值
Front Oncol. 2022 Feb 3;12:800904. doi: 10.3389/fonc.2022.800904. eCollection 2022.
8
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard.阴性前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描能否避免新诊断前列腺癌患者进行盆腔淋巴结清扫？一项以病理组织学为参考标准的系统评价和Meta分析
Eur Urol Oncol. 2022 Feb;5(1):1-17. doi: 10.1016/j.euo.2021.08.001. Epub 2021 Sep 17.
9
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial.68Ga-PSMA-11 PET 对根治性前列腺切除术和盆腔淋巴结清扫术前盆腔淋巴结转移检测的诊断准确性：一项多中心前瞻性 3 期影像学试验。
JAMA Oncol. 2021 Nov 1;7(11):1635-1642. doi: 10.1001/jamaoncol.2021.3771.
10
Incremental Impact of [ Ga]Ga-PSMA-11 PET/CT in Primary N and M Staging of Prostate Cancer Prior to Curative-Intent Surgery: a Prospective Clinical Trial in Comparison with mpMRI.[68Ga]Ga-PSMA-11 PET/CT 对前列腺癌根治性手术前 N 和 M 分期的增量影响：与 mpMRI 比较的前瞻性临床试验。
Mol Imaging Biol. 2022 Feb;24(1):50-59. doi: 10.1007/s11307-021-01650-9. Epub 2021 Sep 14.